Nicholas Jury, PhD

Nicholas Jury, PhD

Bethesda, Maryland, United States
2K followers 500+ connections

About

Creative and driven scientist with more than sixteen years of scientific project…

Activity

Join now to see all activity

Experience

  • The National Institutes of Health Graphic
  • -

    Bethesda, Maryland, United States

  • -

    Washington, District of Columbia, United States

  • -

    Bethesda, MD

  • -

    Bethesda, MD

  • -

    Bethesda, MD

  • -

    Bethesda, MD

  • -

    Bethesda, MD

  • -

    Bethesda, MD

  • -

    Washington D.C. Metro Area

  • -

    Washington D.C. Metro Area

  • -

    Cincinnati, OH

  • -

    Cincinnati, OH

  • -

    Cincinnati, OH

  • -

    Cincinnati, Ohio

  • -

    Peoria, IL

Education

  • University of Cincinnati Graphic

    University of Cincinnati

    -

    Activities and Societies: The Society for Neuroscience, Ohio Miami Valley Chapter of the Society for Neuroscience

  • -

    Activities and Societies: Beta Beta Beta, Biological Honor Society

    As a student researcher, examined the carcinogenic and toxicological effects of pyrene exposure on hepatocyte cell volume regulation from Rana pipiens. Conducted experiments aimed at validating a cocaine hypoxia model in male Sprague-Dawley rats.

  • -

    Activities and Societies: Phi Theta Kappa, International Honor Society of the Two-Year School

  • -

    Activities and Societies: Illinois Region President for Phi Theta Kappa, International Honor Society of the Two-Year School, and Treasurer for Circle K.

Licenses & Certifications

Volunteer Experience

  • President

    DC Metro Area Chapter of The Society for Neuroscience

    - 2 years 1 month

    Science and Technology

    • Charged with oversight and management of the chapter and its 300 members. Provided strategic direction and supervision to chapter leadership including the vice president, secretary, treasurer, and committee co-chairs. Convened monthly executive committee meetings to review meeting minutes, budget, and progress towards achieving the goals of the chapter.
    • Drafted and submitted the annual chapter grant to support the chapter’s outreach, scientific, and professional development…

    • Charged with oversight and management of the chapter and its 300 members. Provided strategic direction and supervision to chapter leadership including the vice president, secretary, treasurer, and committee co-chairs. Convened monthly executive committee meetings to review meeting minutes, budget, and progress towards achieving the goals of the chapter.
    • Drafted and submitted the annual chapter grant to support the chapter’s outreach, scientific, and professional development activities.
    • Fostered new collaborations with scientific and non-scientific organizations to communicate the societal benefits of neuroscience research to a wide array of audiences.
    • Planned and hosted career development opportunities for chapter members and other scientists including seminars, happy hours, and career panels for research and non-academic careers. Organized and participated in the chapter’s annual meetings which included juried poster sessions, research symposia, and keynote speakers.

  • Committee Member

    Ohio Miami Valley Chapter of the Society for Neuroscience

    - 3 years

    Science and Technology

    Collaborated with members of four regional universities to create an Ohio scientific meeting with poster sessions, research symposia, and a keynote speaker.

  • Committee Member

    Neuroscience Graduate Program Recruitment Committee, University of Cincinnati College of Medicine

    - 2 years 8 months

    Education

    Effectively recruited well-qualified undergraduate students for admission into the Neuroscience Graduate Program. Served as the predecessor for the ambassador program for graduate student recruitment. Interviewed applicants for the doctoral program. Reported to the recruitment committee about the merit of candidates.

Publications

  • NMDA receptor GluN2A subunit deletion protects against dependence-like ethanol drinking

    Behavioural Brain Research

    The N-methyl-D-aspartate receptor (NMDAR) is mechanistically involved in the behavioral and neurophysiological effects of alcohol, but the specific role of the GluN2A subunit remains unclear. Here, we exposed mice with constitutive GluN2A gene knockout (KO) to chronic intermittent ethanol vapor (CIE) and tested for EtOH consumption/preference using a two-bottle choice paradigm, as well as NMDAR-mediated transmission at basolateral amygdala synapses via ex vivo slice electrophysiology. Results…

    The N-methyl-D-aspartate receptor (NMDAR) is mechanistically involved in the behavioral and neurophysiological effects of alcohol, but the specific role of the GluN2A subunit remains unclear. Here, we exposed mice with constitutive GluN2A gene knockout (KO) to chronic intermittent ethanol vapor (CIE) and tested for EtOH consumption/preference using a two-bottle choice paradigm, as well as NMDAR-mediated transmission at basolateral amygdala synapses via ex vivo slice electrophysiology. Results showed that GluN2A KO mice attained comparable blood EtOH levels in response to CIE exposure, but did not exhibit the significant increase in EtOH drinking that was observed in CIE-exposed wildtypes. GluN2A KO mice also showed no alterations in BLA NMDAR-mediated synaptic transmission after CIE, relative to air-exposed, whereas C57BL/6 J mice showed an attenuated synaptic response to GluN2B antagonism. Taken together, these data add to mounting evidence supporting GluN2A-containing NMDARs as a mechanism underlying relative risk for developing EtOH dependence after repeated EtOH exposure.

    Other authors
    See publication
  • Characterization of mammary-specific disruptions for Tph1 and Lrp5 during murine lactation

    Scientific Reports

    Serotonin is a homeostatic regulator of the mammary gland during lactation. The contribution of mammary-derived serotonin to circulating serum serotonin concentrations was previously unknown. We have developed mice with mammary-specific disruptions of tryptophan hydroxylase 1 (Tph1) or low-density lipoprotein receptor-related protein 5 (Lrp5) that are induced during late pregnancy and lactation via use of the whey acidic protein (WAP)-Cre cre-lox system. Our objective was to characterize dams…

    Serotonin is a homeostatic regulator of the mammary gland during lactation. The contribution of mammary-derived serotonin to circulating serum serotonin concentrations was previously unknown. We have developed mice with mammary-specific disruptions of tryptophan hydroxylase 1 (Tph1) or low-density lipoprotein receptor-related protein 5 (Lrp5) that are induced during late pregnancy and lactation via use of the whey acidic protein (WAP)-Cre cre-lox system. Our objective was to characterize dams with a lactation- and mammary-specific disruption of Lrp5 (WAP-Cre × Lrp5FL/FL) or Tph1 (WAP-Cre × Tph1FL/FL). Milk yield and pup weights were recorded throughout lactation. Dams were euthanized on d10 postpartum and mammary glands and duodenal tissue were harvested. WAP-Cre × Lrp5FL/FL dams had elevated serotonin concentrations in both the mammary gland and circulation compared to controls. In contrast, WAP-Cre × Tph1FL/FL dams had decreased mammary gland and serum serotonin concentrations compared to controls. Alveolar morphology, milk yield, and pup weights were similar. Mammary-derived serotonin makes a significant contribution to circulating serotonin concentrations during lactation, with no effect on milk yield or alveolar morphology. These transgenic models can and should be confidently used in future lactation studies to further elucidate the contribution of serotonin to the maintenance of lactation.

    Other authors
    See publication
  • Chronic ethanol during adolescence impacts corticolimbic dendritic spines and behavior

    Alcoholism: Clinical and Experimental Research

    The neural and behavioral consequences of alcohol exposure during adolescence remains incomplete. Here, we examined the neurobehavioral impact of adolescent chronic intermittent EtOH (CIE) vapor exposure in C57BL/6J Thy1-EGFP mice. Exposure to CIE during adolescence altered dendritic spine density and morphology in infralimbic (IL) and basolateral amygdala (BLA) neurons, in parallel with a set of behavioral alterations. Together, these data add to growing evidence that key corticolimbic…

    The neural and behavioral consequences of alcohol exposure during adolescence remains incomplete. Here, we examined the neurobehavioral impact of adolescent chronic intermittent EtOH (CIE) vapor exposure in C57BL/6J Thy1-EGFP mice. Exposure to CIE during adolescence altered dendritic spine density and morphology in infralimbic (IL) and basolateral amygdala (BLA) neurons, in parallel with a set of behavioral alterations. Together, these data add to growing evidence that key corticolimbic circuits are vulnerable to the effects of alcohol during adolescence, with lasting, potentially detrimental, consequences for behavior.

    Other authors
  • Drunk Bugs: Chronic Vapour Alcohol Exposure Induces Marked Changes in the Gut Microbiome in Mice

    Behavioural Brain Research

    The gut microbiota includes a community of bacteria that and play an integral part in host health and biological processes. Pronounced and repeated findings have linked gut microbiome to stress, anxiety, and depression. Currently, however, there remains only a limited set of studies focusing on microbiota change in substance abuse, including alcohol use disorder. To date, no studies have investigated the impact of vapour alcohol administration on the gut microbiome. For research on gut…

    The gut microbiota includes a community of bacteria that and play an integral part in host health and biological processes. Pronounced and repeated findings have linked gut microbiome to stress, anxiety, and depression. Currently, however, there remains only a limited set of studies focusing on microbiota change in substance abuse, including alcohol use disorder. To date, no studies have investigated the impact of vapour alcohol administration on the gut microbiome. For research on gut microbiota and addiction to proceed, an understanding of how route of drug administration affects gut microbiota must first be established. Animal models of alcohol abuse have proven valuable for elucidating the biological processes involved in addiction and alcohol-related diseases. This is the first study to investigate the effect of vapour route of ethanol administration on gut microbiota in mice. Adult male C57BL/6J mice were exposed to 4 weeks of chronic intermittent vapourized ethanol (CIE, N = 10) or air (Control, N = 9). Faecal samples were collected at the end of exposure followed by 16S sequencing and bioinformatic analysis. Robust separation between CIE and Control was seen in the microbiome, as assessed by alpha (Shannon and Simpson index, p < 0.05) and beta (ANOSIM, p < 0.001) diversity, with a notable decrease in alpha diversity in CIE. These results demonstrate that CIE exposure markedly alters the gut microbiota in mice. Significant increases in genus Alistipes (p < 0.001) and significant reductions in genra Clostridium IV and XIVb (Kruskal-Wallis, p < 0.001), Dorea (Kruskal-Wallis, p < 0.01), and Coprococcus (Kruskal-Wallis, p < 0.01) were seen between CIE mice and Control. These findings support the viability of the CIE method for studies investigating the microbiota-gut-brain axis and align with previous research showing similar microbiota alterations in inflammatory states during alcoholic hepatitis and psychological stress.

    Other authors
    • Veronica Peterson
    • Raúl Cabrera-Rubio
    • Lorraine A. Draper
    • Fiona Crispie
    • Paul D. Cotter
    • Timothy G. Dinan
    • Andrew Holmes
    • John F. Cryan
    See publication
  • Sex differences in the behavioral sequelae of chronic ethanol exposure

    Alcohol

    Rates of alcohol use disorders (AUDs) differ between men and women, and there is also marked variation between sexes in the effects of acute and chronic alcohol. In parallel to observations in humans, prior studies in rodents have described male/female differences across a range of ethanol (EtOH)-related behaviors, including EtOH drinking. Nonetheless, there remain gaps in our knowledge of the role of sex in moderating the effects of EtOH, particularly in models of chronic EtOH exposure. The…

    Rates of alcohol use disorders (AUDs) differ between men and women, and there is also marked variation between sexes in the effects of acute and chronic alcohol. In parallel to observations in humans, prior studies in rodents have described male/female differences across a range of ethanol (EtOH)-related behaviors, including EtOH drinking. Nonetheless, there remain gaps in our knowledge of the role of sex in moderating the effects of EtOH, particularly in models of chronic EtOH exposure. The goal of the current study was to assess various behavioral sequelae of
    exposing female C57BL/6J mice to chronic intermittent EtOH (CIE) via EtOH vapors. Following four weeks of CIE exposure, adult male and female mice were compared for EtOH drinking in a two-bottle paradigm, for sensitivity to acute EtOH intoxication (via loss of righting reflex, LORR) and for anxiety-like behaviors in the novelty-suppressed feeding and marble burying assays. Next, adult and adolescent females were tested on two different two-bottle drinking preparations (fixed or escalating EtOH concentration) after CIE. Results showed that males and females exhibited significantly blunted EtOH-induced LORR following CIE, whereas only males showed increased anxiety-like behavior after CIE. Increased EtOH drinking after CIE was also specific to males, but high baseline drinking in females may have occluded detection of a CIE-induced effect. The failure to observe elevated drinking in females in response to CIE was also seen in females exposed to CIE during adolescence, regardless of whether a fixed or escalating EtOH-concentration two-bottle procedure was employed. Collectively, these data add to the literature on sex differences in EtOH-related behaviors and provide a foundation for future studies examining how the neural
    consequences of CIE might differ between males and females.

    Other authors
    • Jeffrey DiBerto
    • Thomas Kash
    • Andrew Holmes
  • Reduced ethanol drinking following selective cortical interneuron deletion of the GluN2B NMDA receptors subunit

    Alcohol

    N-Methyl-d-aspartate receptors (NMDAR) are involved in the regulation of alcohol drinking, but the contribution of NMDAR subunits located on specific neuronal populations remains incompletely understood. The current study examined the role of GluN2B-containing NMDARs expressed on cortical principal neurons and cortical interneurons in mouse ethanol drinking. Consumption of escalating concentrations of ethanol was measured in mice with GluN2B gene deletion in either cortical principal neurons…

    N-Methyl-d-aspartate receptors (NMDAR) are involved in the regulation of alcohol drinking, but the contribution of NMDAR subunits located on specific neuronal populations remains incompletely understood. The current study examined the role of GluN2B-containing NMDARs expressed on cortical principal neurons and cortical interneurons in mouse ethanol drinking. Consumption of escalating concentrations of ethanol was measured in mice with GluN2B gene deletion in either cortical principal neurons (GluN2BCxNULL) or interneurons (GluN2BInterNULL), using a two-bottle choice paradigm. Results showed that GluN2BInterNULL, but not GluN2BCxNULL, mice consumed significantly less ethanol, at relatively high concentrations, than non-mutant controls. In a second paradigm in which mice were offered a 15% ethanol concentration, without escalation, GluN2BCxNULL mice were again no different from controls. These findings provide novel evidence for a contribution of interneuronal GluN2B-containing NMDARs in the regulation of ethanol drinking.

    Other authors
    See publication
  • Chronic EtOH effects on putative measures of compulsive behavior in mice

    Addiction Biology

    Addictions, including alcohol use disorders, are characterized by the loss of control over drug seeking and consumption, but the neural circuits and signaling mechanisms responsible for the transition from controlled use to uncontrolled abuse remain incompletely understood. Prior studies have shown that 'compulsive-like' behaviors in rodents, for example, persistent responding for ethanol (EtOH) despite punishment, are increased after chronic exposure to EtOH. The main goal of the current study…

    Addictions, including alcohol use disorders, are characterized by the loss of control over drug seeking and consumption, but the neural circuits and signaling mechanisms responsible for the transition from controlled use to uncontrolled abuse remain incompletely understood. Prior studies have shown that 'compulsive-like' behaviors in rodents, for example, persistent responding for ethanol (EtOH) despite punishment, are increased after chronic exposure to EtOH. The main goal of the current study was to assess the effects of chronic intermittent EtOH (CIE) exposure on multiple, putative measures of compulsive-like EtOH seeking in C57BL/6 J mice. Mice were exposed to two or four weekly cycles of CIE and then, post-withdrawal, tested for progressive ratio responding for EtOH, sustained responding during signaled EtOH unavailability and (footshock) punished suppression of responding for EtOH. Results showed that mice exposed to CIE exhibited attenuated suppression of EtOH seeking during punishment, as compared with air-exposed controls. By contrast, CIE exposure affected neither punished food reward-seeking behavior, nor other putative measures of compulsive-like EtOH seeking. Ex vivo reverse transcription polymerase chain reaction analysis of brain tissue found reduced sensitivity to punished EtOH seeking after CIE exposure was accompanied by a significant increase in gene expression of the GluN1 and GluN2A subunits of the N-methyl-d-aspartate receptor, specifically in the medial orbitofrontal cortex. Moreover, slice electrophysiological analysis revealed increased N-methyl-d-aspartate receptor-mediated currents in the orbitofrontal cortex after CIE exposure in test-naïve mice. Collectively, the current findings add to the growing body of evidence demonstrating that chronic exposure to EtOH fosters resistance to punished EtOH seeking in association with adaptations in cortical glutamatergic transmission.

    Other authors
    See publication
  • 21st Century Cures Act and similar policy efforts: at what cost?

    British Medical Journal

    A controversial proposed law in the United States, the 21st Century Cures Act, is described by supporters as an innovative attempt to jump start the process of finding new cures for the thousands of diseases that currently lack effective treatments. But would this bill promote new cures, or increase the availability of new medical products that do not necessarily work? Alzheimer’s disease is often cited as an example of a devastating disease with enormous costs and no cure in sight. We examine…

    A controversial proposed law in the United States, the 21st Century Cures Act, is described by supporters as an innovative attempt to jump start the process of finding new cures for the thousands of diseases that currently lack effective treatments. But would this bill promote new cures, or increase the availability of new medical products that do not necessarily work? Alzheimer’s disease is often cited as an example of a devastating disease with enormous costs and no cure in sight. We examine the potential harms and costs that would have been incurred by three Alzheimer’s drugs that were rejected under current Food and Drug Administration approval standards but could have been approved under the standards promoted by 21st Century Cures and similar legislation.

    Other authors
    See publication
  • NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism

    Behavioral Brain Research

    Drugs targeting the glutamate N-methyl-d-aspartate receptor (NMDAR) may be efficacious for treating mood disorders, as exemplified by the rapid antidepressant effects produced by single administration of the NMDAR antagonist ketamine. Though the precise mechanisms underlying the antidepressant-related effects of NMDAR antagonism remain unclear, recent studies implicate specific NMDAR subunits, including GluN2A and GluN2B, as well as the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid…

    Drugs targeting the glutamate N-methyl-d-aspartate receptor (NMDAR) may be efficacious for treating mood disorders, as exemplified by the rapid antidepressant effects produced by single administration of the NMDAR antagonist ketamine. Though the precise mechanisms underlying the antidepressant-related effects of NMDAR antagonism remain unclear, recent studies implicate specific NMDAR subunits, including GluN2A and GluN2B, as well as the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPAR) subunit glutamate receptor interacting molecule, PSD-95. Here, integrating mutant and pharmacological in mice, we investigated the contribution of these subunits and molecules to antidepressant-related behaviors and the antidepressant-related effects of the GluN2B blocker, Ro 25-6981. We found that global deletion of GluA1 or PSD-95 reduced forced swim test (FST) immobility, mimicking the antidepressant-related effect produced by systemically administered Ro 25-6981 in C57BL/6J mice. Moreover, the FST antidepressant-like effects of systemic Ro 25-6981 were intact in mutants with global GluA1 deletion or GluN1 deletion in forebrain interneurons, but were absent in mutants constitutively lacking GluN2A or PSD-95. Next, we found that microinfusing Ro 25-6981 into the medial prefrontal cortex (mPFC), but not basolateral amygdala, of C57BL/6J mice was sufficient to produce an antidepressant-like effect. Together, these findings extend and refine current understanding of the mechanisms mediating antidepressant-like effects produced by NMDAR-GluN2B antagonists, and may inform the development of a novel class of medications for treating depression that target the GluN2B subtype of NMDAR

    Other authors
    See publication
  • Enhanced responsivenes to selective serotonin reuptake inhibitors during lactation

    PLoS One

    The physiology of mood regulation in the postpartum is poorly understood despite the fact that postpartum depression (PPD) is a common pathology. Serotonergic mechanisms and their dysfunction are widely presumed to be involved, which has led us to investigate whether lactation induces changes in central or peripheral serotonin (5-HT) systems and related affective behaviors. Brain sections from lactating (day 10 postpartum) and age-matched nulliparous (non-pregnant) C57BL/6J mice were…

    The physiology of mood regulation in the postpartum is poorly understood despite the fact that postpartum depression (PPD) is a common pathology. Serotonergic mechanisms and their dysfunction are widely presumed to be involved, which has led us to investigate whether lactation induces changes in central or peripheral serotonin (5-HT) systems and related affective behaviors. Brain sections from lactating (day 10 postpartum) and age-matched nulliparous (non-pregnant) C57BL/6J mice were processed for 5-HT immunohistochemistry. The total number of 5-HT immunostained cells and optical density were measured. Lactating mice exhibited lower immunoreactive 5-HT and intensity in the dorsal raphe nucleus when compared with nulliparous controls. Serum 5-HT was quantified from lactating and nulliparous mice using radioimmunoassay. Serum 5-HT concentrations were higher in lactating mice than in nulliparous controls. Affective behavior was assessed in lactating and non-lactating females ten days postpartum, as well as in nulliparous controls using the forced swim test (FST) and marble burying task (MBT). Animals were treated for the preceding five days with a selective serotonin reuptake inhibitor (SSRI, citalopram, 5mg/kg/day) or vehicle. Lactating mice exhibited a lower baseline immobility time during the FST and buried fewer marbles during the MBT as compared to nulliparous controls. Citalopram treatment changed these behaviors in lactating mice with further reductions in immobility during the FST and decreased marble burying. In contrast, the same regimen of citalopram treatment had no effect on these behaviors in either non-lactating postpartum or nulliparous females. Our findings demonstrate changes in both central and peripheral 5-HT systems associated with lactation, independent of pregnancy. They also demonstrate a significant interaction of lactation and responsiveness to SSRI treatment, which has important implications in the treatment of PPD.

    Other authors
    • Betsy McCormick
    • Stephen Benoit
    • Nelson Horseman
    • Karen Gregerson
    See publication

Honors & Awards

  • 2023 NIH Director's Award

    National Institutes of Health

    This award is being conferred for the outstanding work as a member of the The NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility Working Group, nominated by the Office of the Director, "In recognition of outstanding contributions to advance the NIH Mission through development of the NIH-Wide Strategic Plan for DEIA".

  • 2021 NHLBI Group Award: BioData Catalyst Team

    National Heart, Lung, and Blood Institute

    For extraordinary expertise and collaboration in launching a cloud-based data-sharing ecosystem and the world’s largest and most racially diverse data set.

  • 2020 OSPEEC Golden Shovel Award for Completion of the Data Visualiazation Project

    National Heart, Lung, and Blood Institute

    Awarded in recognition of my leadership in developing and overseeing the successful launch of data webpages including graphical representations of heart, lung, blood, and sleep diseases and disorders statistics, and NHLBI's budget and grant funding success rates.

  • 2020 NHLBI Group Award: BRAIN and Research Advances and Data Visualization (RAD) Team

    National Heart, Lung, and Blood Institute

    Co-recipient of the award in recognition of my exceptional teamwork for effectively capturing, curating, and communicating NHLBI’s research advances for the Biomedical Research Advanced Information Network (BRAIN).

  • 2020 NHLBI Group Award: COVID-19 Information & Inquiry Response Team

    National Heart, Lung, and Blood Institute

    Co-recipient of the award in recognition of my exemplary efforts to respond to the COVID-19 pandemic through quick planning, for reconsidering normal operations to accommodate the tremendous surge for information from NHLBI stakeholders and the public at large, and for working collaboratively to ensure NHLBI's commitment to address the information needs with the development of a COVID-19 inquiry response strategy.

  • 2020 NHLBI Group Award: COVID-19 Rapid Response Team

    National Heart, Lung, and Blood Institute

    Co-recipient of the award in recognition of my exemplary efforts to respond to the COVID-19 pandemic through quick planning and exceptional teamwork during the extraordinary and rapid implementation of the NHLBI strategic priorities for the COVID-19 pandemic.

  • 2020 NHLBI Group Award: TOPMed Imputation Server Public Release Group

    National Heart, Lung, and Blood Institute

    Co-recipient of the award in recognition of my exceptional teamwork in identifying policy and technical solutions to make the TOPMed Imputation Server available for free and open public use, even amid the challenging times we continue to face as a NHLBI community this year.

  • Distinguished Achievement Award (2020)

    Kelly Government Solutions

    In recognition of my key role in preparing a report to Congress describing NIH's research investments and priorities related to Postural Orthostatic Tachycardia Syndrome (POTS). This was a challenging project because there are substantial differences in opinion among physicians, patients, and even scientists about causes of POTS and the best treatments for it. My work to synthesize the complex research findings and conclusions was critical in completing the report and submitting it to…

    In recognition of my key role in preparing a report to Congress describing NIH's research investments and priorities related to Postural Orthostatic Tachycardia Syndrome (POTS). This was a challenging project because there are substantial differences in opinion among physicians, patients, and even scientists about causes of POTS and the best treatments for it. My work to synthesize the complex research findings and conclusions was critical in completing the report and submitting it to Congress in a timely manner.

  • OSPEEC Award for Excellence

    NHLBI Office of Science Policy, Engagement, Education, and Communications

    Awarded in recognition of my contributions on a report to Congress on Postural Orthostatic Tachycardia Syndrome

  • 2018 NHLBI Director's Award for Scientific Innovation

    National Heart, Lung, and Blood Institute

    Co-recipient of the Scientific Innovation Award in recognition of my essential contributions as part of the Regenerative Medicine Innovation Project Team.

  • 2018 NHLBI Group Award

    National Heart, Lung, and Blood Institute

    Co-recipient of the award in recognition for the trans-NHLBI collaboration in response to the 21st Century Cures Act, an effort with a significant scope and need to be innovative to meet short and unprecedented timelines. For embracing an opportunity to catalyze a focused and systematic trans‐NIH approach to fostering transformative advances in the field, while upholding patient safety, public trust, and the integrity of clinical research in regenerative medicine.

  • 2018 NIH Director's Award

    National Institutes of Health

    Presented to the members of the Regenerative Medicine Innovation Project Team for conceptualizing and implementing the Regenerative Medicine Innovation Project to accelerate progress and stimulate innovation and partnerships in regenerative medicine using adult stem cells.

  • 2017 NHLBI Group Award

    National Heart, Lung, and Blood Institute

    Co-recipient of the award as part of the Regenerative Medicine Innovation Project Team

  • Fellow's Award for Research Excellence (FARE) 2015

    National Institutes of Health (NIH)

    I was privileged to receive the Fellow's Award for Research Excellence for the fiscal year 2015. This prestigious award includes a $1000 travel award for the presentation of scientific data at an international meeting.

    Dr. Francis Collins, Director of the NIH, presided over an awards ceremony honoring all of the FARE winners, and a photograph with all of the honored fellows.

  • Best Poster Presentation in Life Sciences and Medicine

    University of Cincinnati Graduate School Poster Forum

    I was honored to accept the prize for best poster presentation for my poster entitled, "Increased responsiveness to selective serotonin reuptake inhibitors during lactation is specific to mood-related behaviors in mice."

Languages

  • Spanish

    Limited working proficiency

  • English

    Native or bilingual proficiency

Organizations

  • DC Metro Area Chapter of the Society for Neuroscience

    President

    - Present

    Oversaw the executive committee and convened monthly meetings. Wrote and was successfully awarded the annual chapter grant to support outreach, scientific, and professional development activities.

  • Society for Behavioral Neuroendocrinology (SBN)

    Member, Public Policy and Advocacy Committee

    -

    Policy and Scientific Writer: -Translated key research findings from society members into communication materials and synopses for different target audiences. -Gathered feedback from society members to address specific concerns related to biomedical research funding. -Collaborated with members of the committee to draft and edit official responses to requests for information from NIH.

  • NIH Science Policy Discussion Group

    Postdoctoral Member

    -

    Policy Writer/Editor: “Science Policy for All” blog. -Translated complex scientific information into a format for a general audience. -Wrote articles about science and health issues and their potential impact on policy. Discussion Leader: -Organized and led group discussions about timely health and science policy issues. -Invited experts to give presentations about current trends in health and science policy.

More activity by Nicholas

View Nicholas’ full profile

  • See who you know in common
  • Get introduced
  • Contact Nicholas directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses